Skip to Content

C1 66 (Lamivudine 150 mg)

Pill with imprint C1 66 is White, Capsule-shape and has been identified as Lamivudine 150 mg. It is supplied by Cipla USA Inc..

Lamivudine is used in the treatment of hepatitis b; hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Lamivudine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for C1 66

Lamivudine

Imprint
C1 66
Strength
150 mg
Color
White
Size
12.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cipla USA Inc.
National Drug Code (NDC)
69097-0166
Inactive Ingredients
hypromellose 2910 (15 mPa.s), magnesium stearate, microcrystalline cellulose, sodium starch glycolate type B potato, polyethylene glycol 6000, corn starch, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "C1 66"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.